Butalbital/Paracetamol

Butalbital/Paracetamol

DEA Class;  Rx

Common Brand Names; Phrenilin Forte, Phrenilin, Bupap, Orbivan CF

  • Analgesics, Barbiturate Combos

Acetaminophen and barbiturate (butalbital) analgesic combination
Used to treat tension headaches in adult and pediatric patients 12 years and older; prolonged use not advisable
Associated with concerns of abuse, medication-overuse headache, and withdrawal; boxed warning for acetaminophen hepatotoxicity risk

For the treatment of the symptom complex of tension (muscle contraction) headache.

Hypersensitivity

Hepatitis or severe hepatic/renal impairment

Repeated administration in patients w/ anemia, cardiovascular, pulmonary, or renal disease

Porphyria

Butalbital

  • Dizziness, drowsiness, feeling of intoxication, lightheadedness, sedation

  • Abdominal pain, nausea, vomiting

  • Shortness of breath

Acetaminophen

  • Angioedema, laryngeal edema

  • Pruritic maculopapular rash urticaria

  • Agranulocytosis, leukopenia, neutropenia, pancytopenia thrombocytopenia, thrombocytopenic purpura

  • Hepatotoxicity

  • Anaphylactoid reaction

Acetaminophen associated with cases of acute liver failure, at times resulting in liver transplant and death; risk increases in individuals with underlying liver disease, alcohol ingestion, and/or use of more than 1 acetaminophen-containing product (see Black Box Warnings)

Acetaminophen: Risk for rare, but serious skin reactions that can be fatal; these reactions include Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP); symptoms may include skin redness, blisters and rash

G6PD deficiency

Avoid driving car or operating machinery

Pregnancy category: C

Lactation: excreted in breast milk; caution advised

Adults

Butalbital 300 mg per day PO and acetaminophen 3,900 mg per day PO.

Geriatric

Butalbital 300 mg per day PO and acetaminophen 3,900 mg per day PO.

Adolescents

Butalbital 300 mg per day PO and acetaminophen 3,900 mg per day PO.

Children

12 years: Butalbital 300 mg per day PO and acetaminophen 3,900 mg per day PO.
1 to 11 years: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

FDA is asking manufacturers to limit acetaminophen in prescription products to 325 mg/dosage unit; manufacturers have until January 14, 2014 to comply

butalbital/acetaminophen

tablet

  • 50mg/300mg (Orbivan CF)
  • 50mg/325mg (Phrenilin)
  • 50mg/650mg (Bupap)

capsule

  • 50mg/650mg (Phrenilin Forte)
DrugsAce
Logo